Krakowski Andrew C, Dohil Magdalene A
University of California, San Diego, CA, USA.
Semin Cutan Med Surg. 2008 Jun;27(2):161-7. doi: 10.1016/j.sder.2008.04.003.
With a prevalence of 10% to 20% in the first decade of life, atopic dermatitis (AD) is one of the most common skin disorders in young children. It is a chronic illness with limited therapeutic options. Topical anti-inflammatory agents remain at the core of medical management; however, their efficacy must be balanced with safety concerns, especially as they relate to the pediatric population. This article discusses the principles of topical AD therapy with a detailed review of the differences between topical corticosteroids and topical calcineurin inhibitors. It also includes specialized topical treatment strategies for AD, such as wet wraps and diluted bleach baths, and highlights the most common challenges to patient compliance in atopic dermatitis.
在生命的第一个十年中,特应性皮炎(AD)的患病率为10%至20%,是幼儿中最常见的皮肤疾病之一。它是一种治疗选择有限的慢性疾病。局部抗炎药仍然是药物治疗的核心;然而,它们的疗效必须与安全问题相平衡,尤其是与儿科人群相关的安全问题。本文讨论了局部AD治疗的原则,并详细回顾了局部皮质类固醇和局部钙调神经磷酸酶抑制剂之间的差异。它还包括AD的特殊局部治疗策略,如湿包裹和稀释漂白浴,并强调了特应性皮炎患者依从性方面最常见的挑战。